Compare CRBP & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRBP | OGI |
|---|---|---|
| Founded | 2009 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.4M | 189.5M |
| IPO Year | 2014 | 2015 |
| Metric | CRBP | OGI |
|---|---|---|
| Price | $7.54 | $1.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $45.50 | N/A |
| AVG Volume (30 Days) | 616.9K | ★ 734.5K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,822,272.00 | N/A |
| Revenue This Year | N/A | $20.10 |
| Revenue Next Year | $116.00 | $13.92 |
| P/E Ratio | ★ N/A | $13.91 |
| Revenue Growth | ★ 97.62 | N/A |
| 52 Week Low | $6.73 | $1.04 |
| 52 Week High | $20.56 | $2.24 |
| Indicator | CRBP | OGI |
|---|---|---|
| Relative Strength Index (RSI) | 34.94 | 35.59 |
| Support Level | N/A | N/A |
| Resistance Level | $8.87 | $1.69 |
| Average True Range (ATR) | 0.97 | 0.05 |
| MACD | -0.41 | 0.01 |
| Stochastic Oscillator | 4.17 | 36.36 |
Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.